Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2004, Vol. 9 ›› Issue (1): 92-95.

Previous Articles     Next Articles

Role of tumor necrosis factor in reperfusion injury following hepatic ischemia and effects of L-arginine

WANG Wan-Tie, LIN Li-Na1, XU Zheng-Jie, XIE Ke-Jian2, WANG Zong-Min3   

  1. Department of Pathophysiology, 1Department of Anesthesiology, the First Affiliated Hospital, 2Analysis Centre, Department of Laboratary Science, 3Department of Pathology, the Second Affiliated Hospital, Wenzhou Medical College, Wenzhou 325027, Zhejiang, China
  • Received:2003-05-12 Revised:2003-06-19 Online:2004-01-26 Published:2020-11-16

Abstract: AIM: To explore the role of tumor necrosis factor (TNF) in rabbits and patients with hepatic ischemia-reperfusion injury (HIRI) and the effects of L-Arginine (L-Arg) on the injury.METHODS: Changes of the several parameters and the effects of L-Arg were observed during HIRI in 20 rabbits and 18 patients who were scheduled for elective hepatic surgery.The parameters included TNF, alanine aminotrasferase (ALT) and changes of hepatocytes morphologically.RESULTS: TNF content and ALT activities increased (P<0.05 and P<0.01), and the abnormal changes of hepatocytes morphologically were obvious during HIRI.There was positive correlation between the changes of TNF and ALT (rabbits, r =0.912, P<0.01 and patients, r =0.535, P<0.01) during HIRI.With the treatment of L-Arg, the abnormal changes of all parameters as above and hepatocytes morphologically were all alleviated remarkably (P<0.05 and P<0.01).CONCLUSION: TNF may be one of the primary causes for HIRI, and L-Arg can alleviate HIRI by eliminating TNF.

Key words: hepatic ischemia-reperfusion injury, tumor necrosis factor, L-arginine

CLC Number: